JAVMA news
Drug compounding position statement adopted
Compounding services have become more abundant as veterinary pharmacies multiply and enjoy financial success.
JAVMA news
BSE: Could it happen here? Experts say probably not
As BSE continues its spread in Europe, US authorities are fine-tuning defensive actions to prevent the arrival and spread of the disease
JAVMA news
AVMA maintains high profile through meeting attendance
The Executive Board authorized AVMA representation at the following meetings.
JAVMA news
Brandt takes office; strikes note of continuity
Brandt takes office; strikes note of continuity
JAVMA news
Human drug shortages noted on new Web site
TAKE NOTICE Human drug shortages noted on new Web site When veterinarians find it hard to obtain an…
JAVMA news
AABP honors standouts
In Vancouver, the AABP recognized seven members deserving of the association's top honors.
David E. Granstrom, DVM, PhD, DACVM (parasitology)
Dr. David E. Granstrom is assistant executive vice president and chief accreditation and certification officer of the AVMA.
JAVMA news
Proposal calls for changes in antimicrobial use
The Food and Drug Administration hopes a guide and draft guide on antimicrobial use and availability
policy
UNDER REVIEWJudicious therapeutic use of antimicrobials in aquatic animal medicine
Aquatic animal veterinarians should use all therapeutants, including antimicrobials, judiciously to restore aquatic animal health, ensure continued…
policy
American Association of Equine Practitioners (AAEP) judicious use of antimicrobials guidelines
The AVMA has endorsed these antimicrobial stewardship guidelines developed by the American Association of Equine Practitioners.
policy
Approval and availability of antimicrobials for use in food-producing animals
The availability and effectiveness of antimicrobials, including medically important antimicrobials, are important to support the health and welfare of…
policy
Adverse event reporting
The AVMA encourages veterinarians to report adverse events, and encourages continued development and strengthening of adverse event reporting systems.
policy
Dietary Supplement Health and Education Act of 1994
The Dietary Supplement Health and Education Act of 1994, which defines dietary supplements for use in humans, does not apply to products intended for…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
policy
Sale of human-label drug products to veterinarians
Because there are a limited number of drugs labeled for use in animals, veterinarians need to have access to human-labeled prescription drugs to…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
MEMBERS ONLYAVMA conflict of interest policy for volunteers
The integrity of the AVMA and its activities depends on the avoidance of conflicts of interest, or even the appearance of such conflicts, by the…
Antimicrobial use and resistance: FAQs for pet owners
AVMA's antimicrobial FAQs provide science-based information to help you make educated decisions about the use of antibiotics and other antimicrobial…
FAQs about extralabel drug use
See answers to common questions about extra-label drug use by veterinarians and the Animal Medicinal Drug Use Clarification Act.
policy
AAAP guidelines for judicious therapeutic use of antimicrobials in poultry
The AVMA has endorsed these guidelines on judicious therapeutic antimicrobial use in poultry production, developed by the American Association of…
policy
Veterinary compounding
Compounding is the customized manipulation of a drug by a veterinarian, or by a pharmacist upon the prescription of a veterinarian, to meet the needs…
policy
Funding of the New Animal Drug Application (NADA) and Abbreviated New Animal Drug Application (ANADA) approval process
To help ensure adequate availability of veterinary drugs, the AVMA supports increased funding of the FDA Center for Veterinary Medicine for the NADA…